Articles published by Sinovac Biotech Ltd.
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer
August 29, 2023
From Sinovac Biotech Ltd.
Via Business Wire
Tickers
SVA
From Sinovac Biotech Ltd.
Via Business Wire
Tickers
SVA
SINOVAC Reports Unaudited First Half of 2023 Financial Results
August 15, 2023
From Sinovac Biotech Ltd.
Via Business Wire
Tickers
SVA
From Sinovac Biotech Ltd.
Via Business Wire
Tickers
SVA
Sinovac Amends Shareholder Rights Plan
February 22, 2023
From Sinovac Biotech Ltd.
Via Business Wire
Tickers
SVA
SINOVAC Reports Unaudited First Half of 2022 Financial Results
December 29, 2022
From Sinovac Biotech Ltd.
Via Business Wire
Tickers
SVA
SINOVAC Varicella Vaccine Prequalified by WHO
November 03, 2022
From Sinovac Biotech Ltd.
Via Business Wire
Tickers
SVA
SINOVAC to Showcase Products at CPHI Frankfurt
October 28, 2022
From Sinovac Biotech Ltd.
Via Business Wire
Tickers
SVA
SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile
September 06, 2022
From Sinovac Biotech Ltd.
Via Business Wire
Tickers
SVA
SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong Kong
August 03, 2022
From Sinovac Biotech Ltd.
Via Business Wire
Tickers
SVA
From Sinovac Biotech Ltd.
Via Business Wire
Tickers
SVA
From Sinovac Biotech Ltd.
Via Business Wire
Tickers
SVA
From Sinovac Biotech Ltd.
Via Business Wire
Tickers
SVA
SINOVAC Polio Vaccine Prequalified by WHO
June 08, 2022
From SINOVAC Biotech Ltd.
Via Business Wire
Tickers
SVA
From Sinovac Biotech Ltd.
Via Business Wire
Tickers
SVA
Sinovac Amends Shareholder Rights Plan
February 22, 2022
From Sinovac Biotech Ltd.
Via Business Wire
Tickers
SVA
SINOVAC Reports Unaudited First Half of 2021 Financial Results
December 30, 2021
From Sinovac Biotech Ltd.
Via Business Wire
Tickers
SVA
Antigua Court of Appeal Rules in Favor of SINOVAC, Upholds 2018 Judgment
December 09, 2021
From SINOVAC Biotech Ltd.
Via Business Wire
Tickers
SVA
SINOVAC Beijing Settled Litigation of Its Business License and Seals
December 03, 2021
From SINOVAC Biotech Ltd.
Via Business Wire
Tickers
SVA
New Research on SINOVAC’s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant
September 09, 2021
From SINOVAC Biotech Ltd.
Via Business Wire
Tickers
SVA
SINOVAC Announces COVID-19 Vaccine Approved for Emergency Use in Chile for Children and Adolescents
September 08, 2021
From SINOVAC Biotech Ltd.
Via Business Wire
Tickers
SVA
From SINOVAC Biotech Ltd.
Via Business Wire
Tickers
SVA
From SINOVAC Biotech Ltd.
Via Business Wire
Tickers
SVA
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.